FindTrial
Sign In

A multicenter study on gene mutation hotspot screening in Chinese breast cancer patients

A multicenter study on gene mutation hotspot screening in Chinese breast cancer patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014423
Enrollment
Unknown
Registered
2018-01-12
Start date
2016-05-01
Completion date
Unknown
Last updated
2018-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Population:none

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 18-70 years; 2. First-time diagnosed of invasive breast cancer; 3. Patients who meet the criteria of new adjuvant therapy; 4. The neoplasms sample(including puncture, minimally invasive, incisional biopsy, surgery) is available; 5. Complete case report is available; 6. Patient/legal representative signed the Patient Informed Consent.

Exclusion criteria

Exclusion criteria: 1. Ductal carcinoma in situ, lobular carcinoma in situ, phyllodes tumors 2. The neoplasms sample(including puncture, minimally invasive, incisional biopsy, surgery) and/or plasma specimen unavailable. 3. Patient/legal representative unsigned the Patient Informed Consent.

Design outcomes

Primary

MeasureTime frame
Gene sequencing;—

Countries

China

Contacts

Public ContactJiandong Wang

General Hospital of PLA

wangjiandong@188.com+86 13910269069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026